Dengue infection : A global concern

Journal of the Medical Association of Thailand

Volumn 85, Issue SUPPL. 1, 2002, Pages

  Pancharoen, Chitsanu ^a   Tantawichien, Terapong ^a   Thisyakorn, Chule ^a   Kulwichit, Wanla ^a   Thisyakorn, Usa ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Dengue Fever; Dengue Hemorrhagic Fever; Dengue Shock Syndrome; Dengue Virus; DF; DHF; DSS

Indexed keywords

DENGUE; ENDEMIC DISEASE; FEMALE; HOSPITALIZATION; HUMAN; INCIDENCE; MALE; METHODOLOGY; MULTIMODALITY CANCER THERAPY; PRIMARY PREVENTION; REVIEW; RISK FACTOR; SURVIVAL RATE; THAILAND; TROPIC CLIMATE; WORLD HEALTH ORGANIZATION;

COMBINED MODALITY THERAPY; DENGUE; ENDEMIC DISEASES; FEMALE; HUMANS; INCIDENCE; MALE; PRIMARY PREVENTION; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; THAILAND; TROPICAL CLIMATE; WORLD HEALTH ORGANIZATION;

EID: 3042798734     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. nd ed. Hamilton, BC: Decker Inc., 2001: 312-4.
2. Rigau-Perez JG, Clark GG, Reiter P, Sanders EJ, Vorndam AV. Dengue and dengue haemorrhagic fever. Lancet 1998; 352: 971-7.
3. Nisalak A, Endy TP, Nimmannitya S. Serotype-specific dengue virus circulation and dengue diseases in Bangkok, Thailand from 1973 to 1999. (Submitted 2001).
4. Thaithumyanon P, Thisyakorn U, Deerojanawong J, Innis BL. Dengue infection during parturition complicated by severe hemorrhage and vertical transmission. Clin Infect Dis 1994; 18: 248-9.
5. th Asian-Pacific Congress of Clinical Biochemistry. September 29-October 4, 1991. Kobe, Japan. Amsterdam: Excerpta Medica, 1992: 985-7.
6. Thisyakorn U, Thisyakorn C. Diseases caused by arboviruses-dengue haemorrhagic fever and Japanese B encephalitis. Med J Aust 1994; 160: 22-6.
7. Thisyakorn U, Nimmannitya S. Nutritional status of children with dengue hemorrhagic fever. Clin Infect Dis 1993; 16: 295-7.
8. Rothman AL, Ennis FA. Immunopathogenesis of dengue haemorrhagic fever. Virology 1999; 257: 1-6.
9. Bethell DB, Flobbe K, Cao XT, et al. Pathophysiologic and prognostic role of cytokines in dengue hemorrhagic fever. J Infect Dis 1998; 177: 778-82.
10. Hober D, Nguyen TL, Shen L, et al. Tumor necrosis factor alpha levels in plasma and whole-blood culture in dengue-infected patients: Relationship between virus detection and pre-existing specific antibodies. J Med Virol 1998; 54: 210-8.
11. Chaturvedi UC, Dhawan R, Mukerjee R. Immunosuppression and cytotoxicity of dengue infection in the mouse model. In: Gubler DJ, Kuno G, eds. Dengue and dengue hemorrhagic fever. Wallingford, UK: CAB International, 1997: 291-311.
12. Huang YH, Lei HY, Liu HS, Lin YS, Liu CC, Yeh TM. Dengue virus infects human endothelial cells and induces IL-6 and IL-8 production. Am J Trop Med Hyg 2000; 63:71-5.
13. Malasit P. Complement and dengue hemorrhagic fever/shock syndrome. Southeast Asian J Trop Med Public Health 1987; 18: 316-20.
14. Halstead SB, O'Rourke EJ. Dengue virus and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody. J Exp Med 1977; 146: 201-17.
15. Halstead SB, O'Rourke EJ, Allison AC. Dengue viruses and mononuclear phagocytes. II. Identify of blood and tissue leukocytes supporting in vitro infection. J Exp Med 1977; 146: 218-29.
16. Halstead SB. Immunological parameters of togavirus disease syndrome. In: Schlesinger RW, ed. The togaviruses. New York: Academic Press, 1980: 107-73.
17. Halstead SB. The pathogenesis of dengue: Molecular epidemiology in infectious disease. Am J Epidemiol 1981; 114: 632-48.
18. Green S, Vaughn DW, Kalayanarooj S, et al. Early immune activation in acute dengue illness is related to development of plasma leakage and disease severity. J Infect Dis 1999; 179: 755-62.
19. Leitmeyer K, Vaughn DW, Watts DM, et al. Dengue virus structural differences that correlate with pathogenesis. J Virol 1999; 73: 4738-47.
20. Murgue B, Roche C, Chungue E, Departs X. Prospective study of the duration and magnitude of viraemia in children hospitalised during the 1996-1997 dengue-2 outbreak in French Polynesia. J Med Virol 2000; 60: 432-8.
21. Sudiro TM, Zivny J, Ishiko H, et al. Analysis of plasma viral RNA levels during acute dengue virus infection using quantitative competitor reverse transcription-polymerase chain reaction. J Med Virol 2001; 63: 29-34.
22. Vaughn DW, Green S, Kalayanarooj S, et al. Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J Infect Dis 2000; 181: 2-9.
23. Guzman MG, Kouri G, Valdes L, et al. Epidemiologic studies on dengue in Santiago de Cuba, 1977. Am J Epidemiol 2000; 152: 793-9.
24. Sangkawibha N, Rojanasuphot S, Ahandrik S, et al. Risk factors in dengue shock syndrome: A prospective epidemiologic study in Rayong, Thailand. I. The 1980 Outbreak. Am J Epidemiol 1984; 120: 653-69.
25. Rico-Hesse R, Harrison LM, Salas RA, et al. Origins of dengue type 2 viruses associated with increased pathogenicity in the Americas. Virology 1997; 230: 244-51.
26. Watts DM, Porter KR, Putvatana P, et al. Failure of secondary infection with American genotype dengue 2 to cause dengue haemorrhagic fever. Lancet 1999; 354: 1431-4.
27. Guzman MG. Dengue haemorrhagic fever in Cuba, 1981: A retrospective seroepidemiologic study. Am J Trop Med Hygiene 1981; 42: 179-84.
28. An J, Kimura-Kuroda J, Hirabayashi Y, Yasui K. Development of a novel mouse model for dengue virus infection. Virology 1999; 263: 70-7.
29. Gubler DJ. Dengue and dengue hemorrhagic fever. Clin Microbiol Rev 1998; 11: 480-96.
30. nd ed. Geneva: WHO, 1997: 12-23.
31. Pancharoen C, Thisyakorn U. Dengue virus infection during infancy. Trans R Soc Trop Med Hyg 2001; 95: 307-8.
32. Pancharoen C, Thisyakorn U. Dengue infection in teenage children. J Infect Dis Antimicrob Agents 2000; 17: 93-6.
33. Tantawichien T, Thisyakorn U, Pisarnpong A, Israsena S, Suwangool P. Dengue fever and dengue hemorrhagic fever in adults. The First International Conference on dengue and dengue haemorrhagic fever, Chiang Mai, Thailand. November 20-24, 2000. Page 16-7. (Abstract).
34. Wells RA, Scott RM, Pavanand K, Sathitsathein V, Chiamudom U, Macdermott RP. Kinetics of peripheral blood leukocyte alteration in Thai children with dengue hemorrhagic fever. Infect Immun 1980; 28: 428-33.
35. Thisyakorn U, Nimmannitya S, Ningsanond V, Soogarun S. Atypical lymphocyte in dengue hemorrhagic fever: Its value in diagnosis. South-east Asian J Trop Med Public Health 1984; 15: 32-6.
36. Wongsawat J, Pancharoen C, Ningsanond V, Thisyakorn U. Kinetics of peripheral blood leukocyte alterations in Thai children with dengue infection. The First International Conference on dengue and dengue haemorrhagic fever, Chiang Mai, Thailand. November 20-24, 2000. Page 37. (Abstract).
37. st International Congress of Tropical Pediatrics; 1989 Nov 8-12; Bangkok, Thailand. Bangkok: Ruen Kaew Press, 1989: 215-7.
38. Murgue B, Cassar O, Guigon M, Chungue E. Dengue virus inhibits human hematopoietic progenitor growth in vitro. J Infect Dis 1997; 175: 1497-501.
39. Lin CF, Lei HY, Liu CC, et al. Generation of IgM anti-platelet autoantibody in dengue patients. J Med Virol 2001; 63: 143-9.
40. Bunyavejchevin S, Tanawattanacharoen S, Taechakraichana N, Thisyakorn U, Tannirandorn Y, Limpaphayom K. Dengue hemorrhagic fever during pregnancy: Antepartum, intrapartum and postpartum management. J Obstet Gynaecol Res 1997; 23: 445-8.
41. Scott RM, Nisalak A, Chiamudom U, Seridhoranakul S, Nimmannitya S. Isolation of dengue viruses from peripheral blood leukocytes of patients with hemorrhagic fever. J Infect Dis 1980; 141: 1-6.
42. Innis BL, Nisalak A, Nimmannitya S, et al. An enzyme-linked immunosorbent assay to charac-terize dengue infections where dengue and Japanese encephalitis co-circulate. Am J Trop Med Hyg 1989; 40: 418-27.
43. Deubel V, Laille M, Hugnot J, et al. Identification of dengue sequences by genomic amplification: rapid diagnosis of dengue virus serotypes in peripheral blood. J Virol Methods 1990; 30: 41-54.
44. Thisyakorn U, Thisyakom C. Dengue hemorrhagic fever : Unusual manifestation and problems in management. JAMA SEA 1994; 10: 102-3.
45. Thisyakorn U, Thisyakorn C. Dengue infection with unusual manifestations. J Med Assoc Thai 1994; 10: 102-3.
46. Nimmannitya S, Thisyakorn U, Hemsrichart V. Dengue hemorrhagic fever with unusual manifestations. Southeast Asian J Trop Med Public Health 1978; 18: 398-406.
47. Thisyakorn U, Thisyakorn C, Limpitikul W, Nisalak A. Dengue infection with central nervous system manifestations. Southeast Asian J Trop Med Public Health 1999; 30: 504-6.
48. Pancharoen C, Thisyakorn U. Neurological manifestations in dengue patients. Southeast Asian J Trop Med Public Health 2001; 32: 341-5.
49. Cam BV, Fonsmark L, Hue NB, Phuong NT, Poulsen A, Heegaaard ED. Prospective case-control study of encephalopathy in children with dengue hemorrhagic fever. Am J Trop Med Hyg 2001; 65: 848-51.
50. Solomon T, Dung NM, Vaughn DW, et al. Neurological manifestations of dengue infection. Lancet 2000; 355: 1053-9.
51. Pancharoen C, Rungsarannont A, Thisyakorn U. Hepatic function in dengue patients. The First International Conference on dengue and dengue haemorrhagic fever, Chiang Mai, Thailand. November 20-24, 2000. Page 22. (Abstract).
52. Innis BL, Myint KSA, Nisalak A. Acute liver failure is one important cause of fatal dengue infection. Southeast Asian J Trop Med Public Health 1990; 21: 695-6.
53. Pancharoen C, Thisyakorn U. Coinfections in dengue patients. Pediatr Infect Dis J 1998; 17: 81-2.
54. Tassniyom S, Vasanawathana S, Chirawatkul A, Rojanasuphot S. Failure of high-dose methylprednisolone in established dengue shock syndrome: A placebo-controlled, double-blind study. Pediatrics 1993; 92: 111-5.
55. Thisyakorn U. Current status of the knowledge on dengue/dengue hemorrhagic fever/dengue shock syndrome in Thailand. IV. Clinical aspects. Mosquito Borne Diseases Bulletin 1994; 11: 61-3.
56. Bhamarapravati N, Tuchinda P, Boonyapaknavik V. Pathology of Thailand hemorrhagic fever: A study of 100 autopsy cases. Ann Trop Med Parasitol 1967; 61: 500-10.
57. Bhamarapravati N, Yoksan S. Live attenuated tetravalent dengue vaccine. Vaccine 2000; 18: S44-7.
58. Kanesa-thasan N, Sun W, Kim-Ahn G, et al. Safety and immunogenicity of attenuated dengue virus vaccines (Avenus Pasteur) in human volunteers. Vaccine 2001; 19: 3179-88.
59. Trent DW, Kinney RM, Huang CYH. Recombinant dengue virus vaccines. In : Gubler DJ, Kuno G, eds. Dengue and Dengue Hemorrhagic Fever. Oxon: CAB International, 1997: 379-403.
60. Kinney RM, Huang CYH. Development of new vaccines against dengue fever and Japanese encephalitis. Intervirology 2001; 44: 176-7.